174 related articles for article (PubMed ID: 8296795)
21. Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation.
Lasky LC; Warkentin PI; Kersey JH; Ramsay NK; McGlave PB; McCullough J
Transfusion; 1983; 23(4):277-85. PubMed ID: 6410549
[TBL] [Abstract][Full Text] [Related]
22. Production of anti-ABO blood group antibodies after minor ABO-incompatible bone marrow transplantation in NOD/SCID/gamma(c)(null) mice.
Tomita H; Fuchimoto Y; Mori T; Kato J; Uemura T; Handa M; Tazawa H; Ohdan H; Okamoto S; Kuroda T
Clin Transplant; 2013; 27(6):E702-8. PubMed ID: 24125194
[TBL] [Abstract][Full Text] [Related]
23. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
Stussi G; Muntwyler J; Passweg JR; Seebach L; Schanz U; Gmür J; Gratwohl A; Seebach JD
Bone Marrow Transplant; 2002 Jul; 30(2):87-93. PubMed ID: 12132047
[TBL] [Abstract][Full Text] [Related]
24. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant.
López A; de la Rubia J; Arriaga F; Jiménez C; Sanz GF; Carpio N; Marty ML
Transfusion; 1998 Mar; 38(3):247-51. PubMed ID: 9563404
[TBL] [Abstract][Full Text] [Related]
25. ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation.
Stussi G; Halter J; Schanz U; Seebach JD
Transfus Apher Sci; 2006 Aug; 35(1):59-69. PubMed ID: 16935028
[TBL] [Abstract][Full Text] [Related]
26. [ABO-incompatible allogeneic bone marrow transplantation].
Xu L; Guo N; Wang S
Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):413-5. PubMed ID: 11721421
[TBL] [Abstract][Full Text] [Related]
27. A controlled trial of recombinant human erythropoietin after bone marrow transplantation.
Link H; Boogaerts MA; Fauser AA; Slavin S; Reiffers J; Gorin NC; Carella AM; Mandelli F; Burdach S; Ferrant A
Blood; 1994 Nov; 84(10):3327-35. PubMed ID: 7949088
[TBL] [Abstract][Full Text] [Related]
28. [Administration of haptoglobin in ABO incompatible bone marrow transplantation].
Ito M; Imoto S; Nakagawa T; Kai S; Hara H
Rinsho Ketsueki; 1990 Oct; 31(10):1716-20. PubMed ID: 2255063
[TBL] [Abstract][Full Text] [Related]
29. [Isoagglutinins after bone marrow transplantation with minor ABO incompatibility].
Wernet D; Mayer G
Beitr Infusionsther; 1992; 30():359-62. PubMed ID: 1284734
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human erythropoietin for long-term persistent anemia after major ABO-incompatible bone marrow transplantation.
Taniguchi S; Yamasaki K; Shibuya T; Asayama R; Harada M; Niho Y
Bone Marrow Transplant; 1993 Oct; 12(4):423. PubMed ID: 8275046
[No Abstract] [Full Text] [Related]
31. A study of the effect of ABO incompatible plasma in platelet concentrates transfused to bone marrow transplant recipients.
Shanwell A; Ringdén O; Wiechel B; Rumin S; Akerblom O
Vox Sang; 1991; 60(1):23-7. PubMed ID: 2053326
[TBL] [Abstract][Full Text] [Related]
32. [Application of double-filtration plasmapheresis in major ABO-incompatible unrelated bone marrow transplantation].
Huang T; Sun J; Liu J; Liu QF; Men FY
Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1438-40. PubMed ID: 16305976
[TBL] [Abstract][Full Text] [Related]
33. Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants.
Cunard R; Marquez II; Ball ED; Nelson CL; Corringham S; Clopton P; Sanchez AP; Lane T; Ward DM
Transfusion; 2014 Jul; 54(7):1857-63. PubMed ID: 24372185
[TBL] [Abstract][Full Text] [Related]
34. Pre-transplant donor-type red cell transfusion is a safe and effective strategy to reduce isohemagglutinin titers and prevent donor marrow infusion reactions in major ABO-mismatched transplants.
Mehta P; Ramprakash S; Raghuram CP; Trivedi D; Dhanya R; Agarwal RK; Faulkner L
Ann Hematol; 2021 Aug; 100(8):2071-2078. PubMed ID: 34148110
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of erythroid engraftment by recombinant human erythropoietin in ABO-compatible, HLA-identical, allogeneic bone marrow transplant patients.
Vannucchi AM; Bosi A; Grossi A; Guidi S; Saccardi R; Lombardini L; Rossi-Ferrini P
Leukemia; 1992 Mar; 6(3):215-9. PubMed ID: 1564959
[TBL] [Abstract][Full Text] [Related]
36. Is the ABO incompatibility a risk factor in bone marrow transplantation?
Rozman P; Kosir A; Bohinjec M
Transpl Immunol; 2005 Aug; 14(3-4):159-69. PubMed ID: 15982558
[TBL] [Abstract][Full Text] [Related]
37. A preliminary report on ABO incompatible bone marrow transplant.
Tan P; Ong YW; Tien SL; Loh TF; Lim ST
Ann Acad Med Singap; 1991 Jul; 20(4):421-8. PubMed ID: 1799251
[TBL] [Abstract][Full Text] [Related]
38. Delayed erythropoiesis after major ABO-incompatible bone marrow transplantation: report of a case.
Tang JL; Lin MT; Wang CH; Lin DT; Chen YC
J Formos Med Assoc; 1990 Oct; 89(10):892-5. PubMed ID: 1981778
[TBL] [Abstract][Full Text] [Related]
39. [Successful treatment of prolonged anemia after major ABO incompatible bone marrow transplantation for a case of myelodysplastic syndrome with recombinant erythropoietin].
Koda K; Hayashi S; Ikeda K; Morita K; Tsuji Y; Takimoto R; Fujisaki Y; Nakazawa O
Rinsho Ketsueki; 1992 Jul; 33(7):991-3. PubMed ID: 1507422
[TBL] [Abstract][Full Text] [Related]
40. Transfusion-related problems following major ABO-incompatible bone marrow transplantation.
Tasaki T; Satoh S; Gotoh K; Fujii K; Sasaki S; Takadate J; Tachibana M; Ono Y; Ishida Y
Transfus Apher Sci; 2003 Apr; 28(2):155-61. PubMed ID: 12679120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
